107 related articles for article (PubMed ID: 15053675)
1. Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry.
Davidson W; McGibbon GA; White PW; Yoakim C; Hopkins JL; Guse I; Hambly DM; Frego L; Ogilvie WW; Lavallée P; Archambault J
Anal Chem; 2004 Apr; 76(7):2095-102. PubMed ID: 15053675
[TBL] [Abstract][Full Text] [Related]
2. Identification of domains of the HPV11 E1 protein required for DNA replication in vitro.
Amin AA; Titolo S; Pelletier A; Fink D; Cordingley MG; Archambault J
Virology; 2000 Jun; 272(1):137-50. PubMed ID: 10873756
[TBL] [Abstract][Full Text] [Related]
3. Subunit affinities and stoichiometries of the human papillomavirus type 11 E1:E2:DNA complex.
Chao SF; Rocque WJ; Daniel S; Czyzyk LE; Phelps WC; Alexander KA
Biochemistry; 1999 Apr; 38(14):4586-94. PubMed ID: 10194380
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.
Hegde RS; Androphy EJ
J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365
[TBL] [Abstract][Full Text] [Related]
5. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.
Hajduk PJ; Dinges J; Miknis GF; Merlock M; Middleton T; Kempf DJ; Egan DA; Walter KA; Robins TS; Shuker SB; Holzman TF; Fesik SW
J Med Chem; 1997 Sep; 40(20):3144-50. PubMed ID: 9379433
[TBL] [Abstract][Full Text] [Related]
6. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.
Baxter MK; McPhillips MG; Ozato K; McBride AA
J Virol; 2005 Apr; 79(8):4806-18. PubMed ID: 15795266
[TBL] [Abstract][Full Text] [Related]
7. The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity.
Dixon EP; Pahel GL; Rocque WJ; Barnes JA; Lobe DC; Hanlon MH; Alexander KA; Chao SF; Lindley K; Phelps WC
Virology; 2000 May; 270(2):345-57. PubMed ID: 10792994
[TBL] [Abstract][Full Text] [Related]
8. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites.
Alexander KA; Phelps WC
Biochemistry; 1996 Jul; 35(30):9864-72. PubMed ID: 8703960
[TBL] [Abstract][Full Text] [Related]
9. Replication-associated activities of purified human papillomavirus type 11 E1 helicase.
Rocque WJ; Porter DJ; Barnes JA; Dixon EP; Lobe DC; Su JL; Willard DH; Gaillard R; Condreay JP; Clay WC; Hoffman CR; Overton LK; Pahel G; Kost TA; Phelps WC
Protein Expr Purif; 2000 Mar; 18(2):148-59. PubMed ID: 10686145
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2.
Okoye A; Cordano P; Taylor ER; Morgan IM; Everett R; Campo MS
Virus Res; 2005 Mar; 108(1-2):1-14. PubMed ID: 15681049
[TBL] [Abstract][Full Text] [Related]
11. An acidic amphipathic helix in the Bovine Papillomavirus E2 protein is critical for DNA replication and interaction with the E1 protein.
Baxter MK; McBride AA
Virology; 2005 Feb; 332(1):78-88. PubMed ID: 15661142
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus.
Enemark EJ; Chen G; Vaughn DE; Stenlund A; Joshua-Tor L
Mol Cell; 2000 Jul; 6(1):149-58. PubMed ID: 10949036
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human papillomavirus DNA replication by small molecule antagonists of the E1-E2 protein interaction.
White PW; Titolo S; Brault K; Thauvette L; Pelletier A; Welchner E; Bourgon L; Doyon L; Ogilvie WW; Yoakim C; Cordingley MG; Archambault J
J Biol Chem; 2003 Jul; 278(29):26765-72. PubMed ID: 12730224
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.
Kurg R; Tekkel H; Abroi A; Ustav M
J Virol; 2006 Nov; 80(22):11218-25. PubMed ID: 16943289
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of the human papillomavirus E1-E2 interaction.
White PW; Faucher AM; Goudreau N
Curr Top Microbiol Immunol; 2011; 348():61-88. PubMed ID: 20676971
[TBL] [Abstract][Full Text] [Related]
16. Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1-E2 protein-protein interaction: a combined medicinal chemistry, NMR and computational chemistry approach.
Goudreau N; Cameron DR; Déziel R; Haché B; Jakalian A; Malenfant E; Naud J; Ogilvie WW; O'meara J; White PW; Yoakim C
Bioorg Med Chem; 2007 Apr; 15(7):2690-700. PubMed ID: 17306550
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the inhibitor binding site in mitochondrial NADH-ubiquinone oxidoreductase by photoaffinity labeling using a quinazoline-type inhibitor.
Murai M; Sekiguchi K; Nishioka T; Miyoshi H
Biochemistry; 2009 Feb; 48(4):688-98. PubMed ID: 19128036
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication.
Narahari J; Fisk JC; Melendy T; Roman A
Virology; 2006 Jul; 350(2):302-11. PubMed ID: 16529788
[TBL] [Abstract][Full Text] [Related]
19. The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain.
Corina K; Grossman SR; Barsoum J; Prakash SS; Androphy EJ; Pepinsky RB
Virology; 1993 Nov; 197(1):391-6. PubMed ID: 8212573
[TBL] [Abstract][Full Text] [Related]
20. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo.
Kurg R; Uusen P; Sepp T; Sepp M; Abroi A; Ustav M
Virology; 2009 Apr; 386(2):353-9. PubMed ID: 19232665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
